5//SEC Filing
Mayersohn Joel David 5
Accession 0001493152-22-004618
CIK 0001310527other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:57 PM ET
Size
11.1 KB
Accession
0001493152-22-004618
Insider Transaction Report
Form 5
Mayersohn Joel David
Director
Transactions
- Award
COMMON STOCK
2021-12-15+400,000→ 400,000 total - Award
Options to buy common stock
2021-08-24+54,000→ 54,000 totalExercise: $0.36Exp: 2031-08-23→ Common Stock (54,000 underlying)
Holdings
- 428,616
COMMON STOCK
- 37,840
Options to buy common stock
Exercise: $0.50From: 2018-12-01Exp: 2028-12-01→ Common Stock (39,840 underlying) - 40,000
Options to buy common stock
Exercise: $0.50From: 2020-01-06Exp: 2030-01-06→ Common Stock (40,000 underlying)
Footnotes (4)
- [F1]This award of shares was made pursuant to Issuer's board of director's approval under Issuer's restricted stock agreement.
- [F2]The total holdings reported on previous Form 5 accidentally included 39,760 shares of common stock that Mr. Mayersohn did not hold.
- [F3]The options vest semi-annually in two equal installments beginning on 02/24/2022.
- [F4]The total holdings reported on previous Form 5 accidentally reported 2000 less options to buy common stock of the Company.
Documents
Issuer
QSAM Biosciences, Inc.
CIK 0001310527
Entity typeother
Related Parties
1- filerCIK 0001588395
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 9:57 PM ET
- Size
- 11.1 KB